$0.283
+0.003 (+0.93%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de MREO por análisis de gráficos similares
Alphio's MREO stock price prediction model matches the current Mereo BioPharma Group PLC tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.28 (-0.85%). The 1-week path is $0.29 (+2.43%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Mereo BioPharma Group PLC?
Mereo BioPharma is not a good buy right now due to significant financial losses and regulatory uncertainties. The current price is $0.29, and the company reported a net income loss of $7.0 million in Q2 2026, which raises serious concerns about its financial health.
MREO cerró en $0.28 el Friday, tras subir +0.93%
Mereo BioPharma Group PLC (MREO) last closed at $0.283, gaining +0.93%. These facts feed the 1-day and 1-week MREO price prediction above.
Factores de la previsión
Los factores de la previsión de Mereo BioPharma Group PLC (MREO) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de MREO, ordenadas por similitud.
Análisis de estacionalidad de MREO
Historically the probability of a positive November return for MREO is 45.45%. January offers the highest probability of a positive month at 55.74%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de MREO
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $1.69 | $1.75 | $1.92 | +517.07% |
| Dec 2026 | $1.80 | $1.89 | $1.93 | +568.54% |
En 2026, se proyecta que Mereo BioPharma Group PLC (MREO) oscile entre $1.69 y $1.93.
Previsión mensual de Mereo BioPharma Group PLC para 2026
En Nov de 2026, se proyecta que Mereo BioPharma Group PLC promedie $1.75, con un mínimo de $1.69 y un máximo de $1.92.
En Dec de 2026, se proyecta que Mereo BioPharma Group PLC promedie $1.89, con un mínimo de $1.80 y un máximo de $1.93.
Artículos relacionados
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.